07.03.2014 Views

ROCKALL CLO B.V. - Irish Stock Exchange

ROCKALL CLO B.V. - Irish Stock Exchange

ROCKALL CLO B.V. - Irish Stock Exchange

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

for each calendar week and (y) to the extent that a Market Value Price<br />

therefor is determined using an Approved Pricing Service, on each<br />

Business Day and (ii) to calculate the Market Value of each Issuer<br />

Investment that is an Unquoted Investment at least quarterly, or with<br />

respect to Unquoted Investments having an aggregate Market Value in<br />

excess of 4 per cent. of Total Capitalisation, at least monthly and (B) on<br />

each Business Day on which any Rated Notes or VF Notes remain<br />

Outstanding, determine whether the Over-Collateralisation Tests have<br />

been satisfied by reference to the then most recent Quoted Issuer<br />

Investment Valuation and/or the then most recent Unquoted Issuer<br />

Investment Valuation (see Condition 5(b) (Over-Collateralisation Testing<br />

and Reporting)).<br />

The Over-Collateralisation Tests<br />

Over-Collateralisation Failure<br />

and Collateralisation Shortfall<br />

Dates<br />

Compliance with the Over-Collateralisation Tests is an obligation of the<br />

Issuer under the Trust Deed. Subject to certain provisos the<br />

Over-Collateralisation Tests are satisfied when either: (1)(a) the Senior<br />

Advance Amount (as defined in the Market Valuation Manual) is greater<br />

than or equal to the Principal Amount Outstanding of Senior Indebtedness<br />

(as defined in Condition 1 (Definitions)), (b) the Class B Notes Advance<br />

Amount (as defined in the Market Valuation Manual) is greater than or<br />

equal to the sum of the Principal Amount Outstanding of Senior<br />

Indebtedness and the Principal Amount Outstanding of the Class B Notes,<br />

(c) the Class C Notes Advance Amount (as defined in the Market Valuation<br />

Manual) is greater than or equal to the sum of the Principal Amount<br />

Outstanding of Senior Indebtedness, the Principal Amount Outstanding of<br />

the Class B Notes and the Principal Amount Outstanding of the Class C<br />

Notes and (d) the Class D Notes Advance Amount (as defined in the<br />

Market Valuation Manual) is greater than or equal to the sum of the<br />

Principal Amount Outstanding of Senior Indebtedness, the Principal<br />

Amount Outstanding of the Class B Notes, the Principal Amount<br />

Outstanding of the Class C Notes and the Principal Amount Outstanding of<br />

the Class D Notes or (2) the Issuer has complied with Condition 5(c)<br />

(Over-Collateralisation Failure and Collateralisation Shortfall Dates). In the<br />

event that the Over-Collateralisation Tests are not satisfied, the Issuer (or<br />

the Collateral Manager on its behalf) is obliged to employ certain strategies<br />

to attempt to ensure compliance within specific timeframes (see<br />

Condition 5(c) (Over-Collateralisation Failure and Collateralisation Shortfall<br />

Dates)).<br />

On the occurrence of a failure to comply with the Over-Collateralisation<br />

Tests, the Issuer will procure that the Collateral Manager, on behalf of the<br />

Issuer, shall, not later than the Business Day following the date on which<br />

the breach occurred (such day being referred to in the Conditions as a<br />

Collateralisation Shortfall Date), furnish the Rating Agencies, the VFN<br />

Agent (for furnishing to the VF Noteholders) and the Trustee with a<br />

Collateralisation Shortfall Valuation Statement. Upon the occurrence of a<br />

Collateralisation Shortfall Date, the Issuer (or the Collateral Manager on its<br />

behalf) shall, inter alia, also employ either the Prepayment Cure<br />

Methodology or the Projection Cure Methodology in order to remedy the<br />

breach of the Over-Collateralisation Tests. Pursuant to the Prepayment<br />

Cure Methodology, the Issuer, or the Collateral Manager on its behalf, is<br />

obliged to make prepayments of the VF Notes and Outstanding Notes (see<br />

Condition 7(e)(i) (Mandatory Redemption upon Over-Collateralisation<br />

Failure)) by reference to the seniority of the same up to the level necessary<br />

to cure the relevant under-collateralisation (see paragraph (i) of<br />

Condition 5(c) (Over-Collateralisation Failure and Collateralisation Shortfall<br />

Dates)). Pursuant to the Projection Cure Methodology which the Issuer, or<br />

the Collateral Manager on its behalf, may elect to adopt instead of the<br />

Prepayment Cure Methodology, the Issuer (or the Collateral Manager on its<br />

behalf) is obliged to furnish the Rating Agencies, the VFN Agent (for<br />

furnishing to the VF Noteholders) and the Trustee with a Projection Cure<br />

Statement showing projected compliance with the Over-Collateralisation<br />

Tests by the Long-Stop Date by means of disposing of certain Issuer<br />

Investments and acquiring others in accordance with a specific set of<br />

timelines and redeeming VF Notes and Notes with the net proceeds of<br />

such disposals and acquisitions and other liquidity available to the Issuer<br />

(see paragraph (ii) of Condition 5(c) (Over-Collateralisation Failure and<br />

Collateralisation Shortfall Dates)). In the event that the application of the<br />

- 8 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!